STOCK TITAN

Prestige Consumer Healthcare Inc. to Release Fiscal 2021 Third Quarter Earnings Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Prestige Consumer Healthcare Inc. (NYSE:PBH) will release its fiscal 2021 third quarter earnings on February 4, 2021, before market opening. A conference call to discuss these results will follow at 8:30 a.m. ET. U.S. and Canadian participants can call 844-233-9440, while international callers can reach 574-990-1016, using conference ID 4948099. Both a live Internet webcast and an archived replay will be available on the company's Investor Relations page. Prestige markets a diverse portfolio of healthcare products in North America and internationally.

Positive
  • None.
Negative
  • None.

TARRYTOWN, N.Y., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 third quarter earnings release on Thursday, February 4, 2021 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

To participate via phone listeners calling from the U.S. and Canada may dial 844-233-9440, or 574-990-1016 internationally, using the conference ID 4948099. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com.

Telephonic replays will be available for approximately one week following completion of the live call and can be accessed at 855-859-2056 within North America, and at 404-537-3406 from outside North America. The conference ID is 4948099.

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.

Investor Relations Contact

Phil Terpolilli, CFA, 914-524-6819

irinquiries@prestigebrands.com


FAQ

When will Prestige Consumer Healthcare release its third quarter earnings for fiscal 2021?

Prestige Consumer Healthcare will release its fiscal 2021 third quarter earnings on February 4, 2021.

What time is the earnings conference call for Prestige Consumer Healthcare scheduled?

The conference call is scheduled for 8:30 a.m. ET on February 4, 2021.

How can I access the earnings call for Prestige Consumer Healthcare?

You can access the call by dialing 844-233-9440 in the U.S. and Canada, or 574-990-1016 internationally, using conference ID 4948099.

Will there be a replay of the Prestige Consumer Healthcare earnings call?

Yes, a telephonic replay will be available for approximately one week after the live call.

Prestige Consumer Healthcare Inc.

NYSE:PBH

PBH Rankings

PBH Latest News

PBH Stock Data

4.23B
48.74M
1.3%
105.91%
4.8%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
TARRYTOWN